Publicacións en colaboración con investigadores/as de GlaxoSmithKline (United Kingdom) (2)

2015

  1. Early prediction of disease progression in small cell lung cancer: Toward model-based personalized medicine in oncology

    Cancer Research, Vol. 75, Núm. 12, pp. 2416-2425

2012

  1. Dabrafenib in BRAF-mutated metastatic melanoma: A multicentre, open-label, phase 3 randomised controlled trial

    The Lancet, Vol. 380, Núm. 9839, pp. 358-365